Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_assertion type Assertion NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_head.
- NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_assertion description "[O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is reported to be a prognostic and predictive factor of alkylating chemotherapy for glioblastoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_provenance.
- NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_assertion evidence source_evidence_literature NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_provenance.
- NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_assertion SIO_000772 25175833 NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_provenance.
- NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_assertion wasDerivedFrom befree-2016 NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_provenance.
- NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_assertion wasGeneratedBy ECO_0000203 NP1215719.RA7Yt82e0rzlNHM8M4cfq8fkwyPMN2wmQ9Ig6AtOnn2BU130_provenance.